About Kee Pharma Limited
Data last updated: 11 January 2026
Kee Pharma Limited is a public limited company based in New Delhi, Delhi, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 08 May 1991, the company has been in operation for over 35 years.
Registered with ROC Delhi under CIN U24239DL1991PLC044264.
Capital: an authorised share capital of ₹11 Cr and a paid-up capital of ₹10.48 Cr. Formerly known as Kee Pharma P Limited. It is led by directors including Anil Motihar and Harinder Motihar.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: A – 8 3Rd Floor Naraina Industrial Area Phase – Ii, New Delhi, Delhi, India – 110028.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.89 Cr, a growth of 3% compared to the previous year.
The company has a workforce of approximately 222 employees as per the latest available data. Its group structure includes 3 subsidiaries.
The company is associated with 1 brand - Kee Pharma. As per MCA filings, the company has open charges of ₹9.5 Cr and satisfied charges of ₹4.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website keepharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressA – 8 3Rd Floor Naraina Industrial Area Phase – Ii, New Delhi, Delhi, India – 110028
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Kee Pharma Limited
Kee Pharma Limited operates one associated brand: Kee Pharma. These brands represent Kee Pharma Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Sells health supplements and products via online store. | keepharma.com |
Competitors & Alternatives of Kee Pharma Limited
Brands and companies operating in the same space as Kee Pharma Limited include Merck, Roivant Sciences, AbbVie and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Merck
|
Pharmaceutical products are manufactured and marketed worldwide. | Kenilworth, United Kingdom, United Kingdom | 1891 |
Roivant Sciences
|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | New York, United States, United States | 2014 |
AbbVie
|
Biopharmaceutical research and drug development are conducted globally by AbbVie. | Chicago, United States, United States | 2012 |
Lilly
|
Traditional pharmaceutical medicines are developed for multiple health fields. | United States | 1876 |
Gilead
|
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | Foster City, United States, United States | 1987 |
United Therapeutics
|
Treatments for chronic and life-threatening diseases are developed and commercialized. | Silver Spring, United States, United States | 1998 |
Roche
|
Pharmaceuticals and diagnostics kits are developed for various diseases. | Basel, Switzerland, Switzerland | 1896 |
Ascendis Pharma
|
Long-acting prodrug therapies are developed for endocrine and rare diseases. | Hellerup, Denmark, Denmark | 2007 |
MorphoSys
|
Therapeutic antibodies for cancer and other diseases are developed. | Planegg, Germany, Germany | 1992 |
Vertex Pharmaceuticals
|
Developer of drugs for the treatment of multiple disorders | United States | 1989 |
Business Activity of Kee Pharma Limited
Kee Pharma Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Kee Pharma Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Kee Pharma Limited
Kee Pharma Limited is audited by MYMR & Associates for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MYMR & Associates | Locked | Locked | Locked |
Complete auditor history for Kee Pharma Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Kee Pharma Limited
Kee Pharma Limited is currently managed by 4 directors, with 7 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Motihar | Managing Director | 09 Nov 1992 | 33 Years 9 Months | Current |
|
Harinder Motihar
Also directs:
Kee Healthcare Private Limited
|
Director | 31 Dec 2015 | 10 Years 7 Months | Current |
| Mohit S Nigam | Additional Director | 15 Dec 2025 | 0 Years 8 Months | Current |
|
Natasha Goyal
Also directs:
Kati Patang Lifestyle Limited, Iboard India Limited, Hindustan Thermalprojects Limited and 2 more
|
Director | 22 Jul 2025 | 1 Years 0 Months | Current |
Financials of Kee Pharma Limited FY 2024 filings available
Kee Pharma Limited reported revenue of ₹18.89 Cr (up 3.00% YoY) for FY 2025.
Ten-year financial statements for Kee Pharma Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Kee Pharma Limited
Shareholding and ownership data for Kee Pharma Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Kee Pharma Limited
Kee Pharma Limited has 3 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Kee Pharma Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Kee Healthcare Private Limited | U24100DL2012PTC232081 | Locked |
| Kee Diagnostics Private Limited | U24231DL2004PTC128343 | Locked |
| Helvetica Industries Private Limited | U24233DL1999PTC098112 | Locked |
Showing major subsidiaries. Total: 3.
Charges & Borrowings of Kee Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Oct 2004 | Indian Bank | ₹2.95 Cr | Open |
| 11 Sep 2003 | Ge Capital Services India | ₹4.5 Lakh | Open |
| 18 Oct 2002 | Nidian Bank | ₹75 Lakh | Open |
| 20 Oct 2000 | Nidian Bank | ₹1 Cr | Open |
| 26 Dec 1999 | Indian Bank | ₹8 Lakh | Open |
Total charge records: 13 View all charges
Employees and EPFO Compliance at Kee Pharma Limited
Kee Pharma Limited has a workforce of 222 employees as of Mar 29, 2024.
Employee and EPFO history for Kee Pharma Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Kee Pharma Limited
GST registrations and filing compliance for Kee Pharma Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Kee Pharma Limited
Credit ratings, litigation, and regulatory alerts for Kee Pharma Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kee Pharma Limited
MSME payment history for Kee Pharma Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kee Pharma Limited
Corporate group structure for Kee Pharma Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kee Pharma Limited
MCA filings and documents for Kee Pharma Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Kee Pharma Limited
Frequently Asked Questions about Kee Pharma Limited
Kee Pharma Limited is an active public limited company in the pharma sector based in New Delhi, Delhi, India. It was incorporated on 08 May 1991 (35+ years old) and is registered under CIN U24239DL1991PLC044264. The company has 222 employees.
Kee Pharma Limited reported revenue of ₹18.89 Cr for FY 2025 (up 3.00% YoY).
The current directors of Kee Pharma Limited are:
- Anil Motihar - Managing Director
- Harinder Motihar - Director
- Mohit S Nigam - Additional Director
- Natasha Goyal - Director
The primary industry of Kee Pharma Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Kee Pharma Limited can be reached at the registered office: A – 8 3Rd Floor Naraina Industrial Area Phase – Ii, New Delhi, Delhi, India – 110028, or through the website keepharma.com.
The authorised capital is ₹11 Cr, and the paid-up capital is ₹10.48 Cr.